|
Adult patient:
Minimum blood volume: 3 mL |
|
|
Paediatric patient: Paediatric EDTA tube Number of vials: 1 Minimum blood volume: 1.3 mL |
|
|
Authorisation code required |
No |
|
24 Hr available service |
No |
| Precaution | Trough level monitoring (pre-dose) |
|
Method |
Liquid chromatography-tandem mass spectrometry |
|
Reference interval |
3 - 8 µg/L
(Source: Norvatis Certican Summary of Product Characteristics) |
|
Clinical indication |
Therapeutic drug monitoring in patients receiving everolimus therapy to avoid rejection of organ transplants and to detect toxic levels. |
|
Result interpretation |
An elevated result provides an early indication of the possibility of toxicity. |
|
Measurement of uncertainty |
|
|
Frequency of measurement |
Weekly |